Fig. 2From: Nivolumab-induced thyroid dysfunction lacking antithyroid antibody is frequently evoked in Japanese patients with malignant melanomaOverview of thyroid immune-related adverse events (irAEs) in patients with melanoma treated with nivolumabThe continuous levothyroxine replacement was needed in two out of three hypothyroid patients who had preceding transient thyrotoxicosis and in only one out of four hypothyroid patients without preceding thyrotoxicosis.Abbreviations: irAE, immune-related adverse eventBack to article page